Related Experiment Videos
[Pseudomembranous colitis in Hirschsprung disease]
Klinische Padiatrie
|September 1, 1983
Abstract:
Pseudomembranous colitis (PMC) is a potentially fatal complication in Hirschsprung's disease. The pathogenesis of PMC which usually takes a fulminant course, is obscure. The disease generally is associated with antibiotic therapy. We describe the clinical course and the pathological findings in a 7 1/2 months old infant with Hirschsprung's disease after surgical treatment. The pseudomembranous colitis of the patient with letal consequence is considered to be connected with antibiotic therapy.
Insights
Pseudomembranous colitis (PMC) is a dangerous complication of Hirschsprung
Area of Science:
- Gastroenterology and Pediatric Surgery
Background:
- Hirschsprung's disease (HSCR) is a congenital disorder characterized by the absence of ganglion cells in the distal bowel.
- Pseudomembranous colitis (PMC) is a severe intestinal inflammation, often linked to antibiotic use, and can be fatal.
- The association between HSCR and PMC, particularly its pathogenesis and outcomes, requires further investigation.
Observation:
- A case study of a 7.5-month-old infant with Hirschsprung's disease following surgical intervention.
- The infant developed pseudomembranous colitis with a fatal outcome.
- The clinical course and pathological findings were meticulously documented.
Findings:
- The pseudomembranous colitis in this patient presented with a fulminant course.
- The pathological findings indicated severe intestinal inflammation consistent with PMC.
- The outcome was lethal, highlighting the severity of this complication.
Implications:
- This case suggests a potential link between antibiotic therapy and the development of pseudomembranous colitis in infants with Hirschsprung's disease.
- Further research is warranted to elucidate the specific mechanisms and risk factors involved.
- Understanding this association may lead to improved management strategies and preventative measures for HSCR patients.